Investigation of the clinical breakpoints of piperacillin-tazobactam against infections caused by Pseudomonas aeruginosa.

Yamagishi, Yuka; Terada, Michinori; Ohki, Emiko; Miura, Yoko; Umemura, Takumi; Mikamo, Hiroshige

Yamagishi, Yuka; Terada, Michinori; Ohki, Emiko; Miura, Yoko; Umemura, Takumi; Mikamo, Hiroshige.

Affiliation

Yamagishi Y; Department of Infection Control and Prevention, Aichi Medical University Graduate School of Medicine, 21 Karimata, Yazako, Nagakute, Aichi, 480-1195, Japan.

J Infect Chemother ; 18(1): 127-9, 2012 Feb.

Article in En | MEDLINE | ID: mdl-21814800

Subject(s)

Anti-Bacterial Agents/pharmacology; Pseudomonas Infections/drug therapy; Pseudomonas aeruginosa/drug effects; Anti-Bacterial Agents/pharmacokinetics; Bacteremia/drug therapy; Bacteremia/microbiology; Cross Infection/drug therapy; Humans; Microbial Sensitivity Tests; Penicillanic Acid/analogs & derivatives; Penicillanic Acid/pharmacokinetics; Penicillanic Acid/pharmacology; Piperacillin/pharmacokinetics; Piperacillin/pharmacology; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial/drug therapy; Pneumonia, Bacterial/microbiology; Pseudomonas Infections/microbiology; Retrospective Studies

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas aeruginosa / Pseudomonas Infections / Anti-Bacterial Agents Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Infect Chemother Journal subject: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2012 Document type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google